Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

Optimising HIV drug resistance testing laboratory networks in Kenya: insights from systems engineering modelling

Domain:

healthcare

Record type:

model
Creator:
YinLeoAnjNas
Publisher:
BMJ
Host:
Background HIV drug resistance (DR) is a growing threat to the durability of current and future HIV treatment success. DR testing (DRT) technologies are very expensive and specialised, relying on centralised laboratories in most low and middle-income countries. Modelling for laboratory network with point-of-care (POC) DRT assays to minimise turnaround time (TAT), is urgently needed to meet the growing demand. Methods We developed a model with user-friendly interface using integer programming and queueing theory to improve the DRT system in Kisumu County, Kenya. We estimated DRT demand based on both current and idealised scenarios and evaluated a centralised laboratory-only network and an optimised POC DRT network. A one-way sensitivity analysis of key user inputs was conducted. Results In a centralised laboratory-only network, the mean TAT ranged from 8.52 to 8.55 working days, and the system could not handle a demand proportion exceeding 1.6%. In contrast, the mean TAT for POC DRT network ranged from 1.13 to 2.11 working days, with demand proportion up to 4.8%. Sensitivity analyses showed that expanding DRT hubs reduces mean TAT substantially while increasing the processing rate at national labs had minimal effect. For instance, doubling the current service rate at national labs reduced the mean TAT by only 0.0%–1.9% in various tested scenarios, whereas doubling the current service rate at DRT hubs reduced the mean TAT by 37.5%–49.8%. In addition, faster batching modes and transportation were important factors influencing the mean TAT. Conclusions Our model offers decision-makers an informed framework for improving the DRT system using POC in Kenya. POC DRT networks substantially reduce mean TAT and can handle a higher demand proportion than a centralised laboratory-only network, especially for children and pregnant women living with HIV, where there is an immediate push to use DRT results for patient case management.

Visit

doi.org

Languages

Kenyan Sign Language

Licenses

http://creativecommons.org/licenses/by-nc/4.0/

Similar

Modelling HIV Drug Resistance in Southern Africa.Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.Diversity of HIV Type 1 and Drug Resistance Mutations Among Injecting Drug Users in KenyaA Multi-Disciplinary Care Model for People with Drug-Resistant HIV: The AMPATH HIV Drug Resistance Clinic in KenyaLeveraging Cohort Data and Mathematical Modelling to Predict HIV Drug Resistance Evolution in South AfricaCOVID-19 mass testing and sequencing: Experiences from a laboratory in Western Kenya

Modelling HIV Drug Resistance in Southern Africa.

Southern Africa is the region most affected by HIV globally. In South Africa, for example, the preva

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.

Increased provision of antiretroviral therapy in sub-Saharan Africa has led to a growing number of p

Diversity of HIV Type 1 and Drug Resistance Mutations Among Injecting Drug Users in Kenya

Drug use in Kenya dates back to the precolonial period but research among drug users in relation to

A Multi-Disciplinary Care Model for People with Drug-Resistant HIV: The AMPATH HIV Drug Resistance Clinic in Kenya

Background: HIV mortality has decreased with the availability of ART (antiretroviral therapy) in res

Leveraging Cohort Data and Mathematical Modelling to Predict HIV Drug Resistance Evolution in South Africa

With the advent of antiretroviral therapy (ART), millions of lives have been saved. However, HIV’s r

COVID-19 mass testing and sequencing: Experiences from a laboratory in Western Kenya

Background: The Basic Science Laboratory (BSL) of the Kenya Medical Research Institute/Walter Reed P